What Tenax Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 14 | 27 |
| Sells | 0 | 0 |
| Total trades | 14 | 30 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 3,688,574 | 3,775,087 |
| Disposed | 0 | 0 |
| Net activity | +3,688,574 | +3,775,087 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, Llc | 10% owner | Oct 21 | Open-market buy · P | +331,979 | $1.66 | +$551K | 7,447,000 |
| ADAR1 Capital Management, Llc | 10% owner | Oct 20 | Open-market buy · P | +254,342 | $1.60 | +$406K | 7,115,021 |
| ADAR1 Capital Management, Llc | 10% owner | Oct 19 | Open-market buy · P | +336,528 | $1.51 | +$507K | 6,860,679 |
| Doogan Declan | Director | Sep 16 | Open-market buy · P | +53,000 | $1.92 | +$102K | 55,274 |
| Giordano Chrisopher Thomas | CEO | Sep 15 | Open-market buy · P | +4,850 | $1.82 | +$8.84K | 22,174 |
| Giordano Chrisopher Thomas | CEO | Sep 11 | Open-market buy · P | +6,000 | $1.88 | +$11.3K | 17,324 |
| Staab Thomas R Ii | Chief Financial Officer | Sep 11 | Open-market buy · P | +5,675 | $1.94 | +$11K | 15,675 |
| ADAR1 Capital Management, Llc | 10% owner | Sep 03 | Open-market buy · P | +900,000 | $1.78 | +$1.6M | 6,524,151 |
| ADAR1 Capital Management, Llc | 10% owner | Sep 02 | Open-market buy · P | +187,704 | $1.80 | +$338K | 5,624,151 |
| ADAR1 Capital Management, Llc | 10% owner | Sep 01 | Open-market buy · P | +179,058 | $1.80 | +$322K | 5,436,447 |
| ADAR1 Capital Management, Llc | 10% owner | Aug 31 | Open-market buy · P | +403,571 | $1.79 | +$723K | 5,257,389 |
| ADAR1 Capital Management, Llc | 10% owner | Aug 24 | Open-market buy · P | +107,374 | $1.75 | +$188K | 4,853,818 |
| ADAR1 Capital Management, Llc | 10% owner | Aug 21 | Open-market buy · P | +716,369 | $1.77 | +$1.27M | 4,746,444 |
| ADAR1 Capital Management, Llc | 10% owner | Aug 20 | Open-market buy · P | +202,124 | $1.78 | +$360K | 4,030,075 |
| Giordano Chrisopher Thomas | CEO | Jul 13 | Exercise / conversion · M | +8,500 | $5.94 | +$50.5K | 11,324 |
| Giordano Chrisopher Thomas | CEO | Jul 13 | Exercise / conversion · M | +219 | $3.55 | +$777 | 2,824 |
| Staab Thomas R Ii | Chief Financial Officer | May 11 | Grant / award · A | +10,000 | — | — | 10,000 |
| Rich Stuart | Chief Medical Officer | Dec 09 | Open-market buy · P | +2,500 | $10.22 | +$25.5K | 5,266 |
| Rich Stuart | Chief Medical Officer | Dec 08 | Open-market buy · P | +2,500 | $10.10 | +$25.3K | 5,000 |
| Rich Stuart | Chief Medical Officer | Dec 04 | Open-market buy · P | +2,500 | $9.20 | +$23K | 2,500 |
Loading...